HIMS Stock Crashes 30% in a Day: Time to Buy the Dip?
HIMS
) has been one of the market's standout growth stocks in recent years. The company has successfully built a direct-to-consumer health platform targeting conditions like hair loss, mental health, and more recently, weight loss—delivering very strong revenue growth and stock returns.
Shares had soared more than 150% (on two separate occasions) through the first half of 2025 before crashing more than 30% on Monday following a major partnership setback.
The selloff was triggered by news that Novo Nordisk (
NVO
) will no longer partner with Hims to supply GLP-1 weight loss drugs like compounded semaglutide. Novo Nordisk cited HIMS' use of custom-compounded versions of its weight-loss drug, along with concerns over the company's sales and promotional tactics, as reasons for ending the partnership.
While the termination of the partnership raises valid concerns for investors, Hims & Hers Health remains a fast-growing company operating in a compelling industry vertical. Below, we'll explore HIMS' business fundamentals, the broader GLP-1 industry landscape, and a tactical approach, the three-day rule, for those considering buying the stock.
Hims and Hers Stock Rallied on Strong Growth
Over the last two years, HIMS stock has been a huge gainer, though it has been accompanied by considerable volatility. Nonetheless, the company continues to enjoy some fairly compelling metrics and forecasts, especially following this large correction.
The company currently holds a Zacks Rank #3 (Hold), indicating mixed, earnings revisions over the last two month. Today, HIMS trades at 41x next year's earnings, a premium valuation, but not unreasonable for a company with such strong growth forecasts.
Earnings are expected to grow at an impressive 36.5% annually over the next three to five years, while sales are projected to rise 58.5% this year and another 22.6% next year.
Novo Nordisk and Eli Lilly Stocks Have Traded Lower
Interestingly, the GLP-1 giants have struggled over the last year. Shares of Novo Nordisk are still down more than 50% from their 2024 highs, while Eli Lilly (
LLY
) has shown more relative strength, though still well off its highs. Both stocks have faced their own challenges, including supply constraints, reimbursement questions, and competition in the obesity drug space. The outperformance of Eli Lilly and massive outperformance of Hims shows investors may favor these names.
Despite the near-term volatility, long-term projections for the GLP-1 market remain massive. Some analysts estimate the global market for GLP-1 weight loss treatments could exceed $150 billion by 2035. While the loss of the Novo partnership is a setback, Hims may still have a path to participating in this growth, either through compounding or alternative partnerships.
Three-Day Rule for Those Interested in Buying HIMS Stock
For investors considering buying the dip, the three-day rule may be worth applying here. As explained in our recent article on UNH, sharp one-day drops on unexpected news often lead to additional downside or volatility in the short term. Giving the stock a few days to settle can help reduce risk and provide a clearer entry point.
Should Investors Buy Shares in HIMS?
HIMS is now a high-risk, high-reward growth stock. The long-term outlook remains compelling given the company's strong revenue growth, expanding customer base, and exposure to major healthcare trends.
However, near-term uncertainty is high. The loss of the Novo partnership, regulatory ambiguity, and premium valuation all suggest caution. Investors may want to let the dust settle before taking a position, but for those willing to stomach the volatility, the selloff could present a long-term opportunity.
Zacks' Research Chief Names "Stock Most Likely to Double"
Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.
This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.
Free: See Our Top Stock And 4 Runners Up
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Novo Nordisk A/S (NVO): Free Stock Analysis Report
Eli Lilly and Company (LLY): Free Stock Analysis Report
Hims & Hers Health, Inc. (HIMS): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CTV News
37 minutes ago
- CTV News
Manitoba port has become a key asset amidst Canada-U.S. trade war
Watch A remote port in Manitoba could play a crucial role as the Canada-U.S. trade war rages on. CTV's Alex Karpa has more.
Globe and Mail
2 hours ago
- Globe and Mail
Prediction: Quantum Computing Stock Will Be Worth This Much in 2030
Key Points Quantum Computing has emerged alongside other popular quantum stocks such as IonQ, Rigetti Computing, and D-Wave Quantum over the last year. While the company's approach to building quantum applications is interesting, past ambitions in other markets and an inconsistent financial profile should make investors pause before blindly buying the hype narrative. Although Quantum Computing has interesting potential, the amount of unknowns surrounding the company's future are hard to ignore. 10 stocks we like better than Quantum Computing › One of the more curious companies that has piqued investor intrigue in the quantum computing market is a business called (wait for it!) Quantum Computing (NASDAQ: QUBT). With a name like that, I wonder how it landed on so many radars. Sarcasm aside, Quantum Computing (the business) deserves a look -- and not just because of its 2,400% share price gains over the last year. To me, the company's technological promises and its actual business just don't align. Let's explore how Quantum Computing is attempting to disrupt the artificial intelligence (AI) realm and then dig into whether or not the company has what it takes to fulfill its lofty ambitions. Is Quantum Computing the next multibagger AI stock? Read on to find out. Quantum Computing might look like an exciting company on the surface, but... Quantum-based applications have the potential to transform the computing industry thanks to their fundamentally differentiated architectures. In simple terms, classical computing is based on binary code, written through a series of bits expressed as 1 or 0. Quantum computing uses qubits, which means they can exist as both 1 and 0 at the same time -- a process known as superposition. This allows for more complex information processing compared to today's classical computers. There are multiple ways that companies are developing qubits. IonQ relies on a process called trapped-ion, which essentially uses lasers to trap atoms and use them as the foundation of a qubit. Meanwhile, other competitors such as Rigetti Computing and D-Wave Quantum use superconducting circuits and quantum annealing techniques to make qubits. Quantum Computing, on the other hand, is using light (photons) as opposed to Rigetti and D-Wave's electricity-based foundation or IonQ's trapped atom technology. In theory, photonic qubits may be more energy efficient and easier to scale than other approaches that are heavily reliant on sophisticated cooling systems. ... there are quite a few red flags to point out Before buying into the idea that Quantum Computing is on the verge of a technological breakthrough, consider the following: Quantum Computing was once known as Innovative Beverage Group Holdings (IBGH). Why did the company pivot from beverages to qubits? Well, consider that IBGH went out of business, and the leftover management team decided to acquire a small company called QPhoton and completely shift its focus to quantum computing. Over the last year, Quantum Computing has generated $385,000 in sales. While the idea of photonic qubits is interesting, Quantum Computing is far from building a competitive moat over its rivals. The company's nominal revenue base and unproven roadmap hint at possible liquidity crunches down the road. For now, Quantum Computing appears to be relying on issuing stock as a means to raise cash and fund the operation. Despite these red flags, Quantum Computing has seen its market value climb from $55 million to $2.4 billion in just one year. QUBT Market Cap data by YCharts The company's valuation is far higher than what investors witnessed during prior stock market bubbles during the internet boom and the COVID-19 stock market euphoria. Where will Quantum Computing stock be in five years? Given the ideas explored above, it's clear that Quantum Computing has virtually nothing to show for its supposed innovative photonic processes. The lack of strategic partners and product-market fit has me thinking that Quantum Computing offers more along the lines of vaporware than anything groundbreaking at this time. With ongoing research and development (R&D) and capital expenditures (capex) required to explore quantum technology, Quantum Computing is likely going to continue tapping the capital markets for liquidity unless some transformative deals begin to take shape -- which I suspect is highly unlikely. In my eyes, Quantum Computing stock is benefiting for one reason above all else. The company's name isn't just associated with one of AI's hottest new themes -- it's literally the name of the actual trend. To me, this is a case study revolving around the idea of investors blindly chasing narratives over sound fundamentals. I think that Quantum Computing is headed toward insolvency and could wind up bankrupt by 2030 (if not sooner). Alternatively, regulators could begin to scrutinize the company more heavily, and Quantum Computing could end up as a delisted stock. Regardless of how things shake out, I think Quantum Computing's equity value will diminish significantly in the coming years. For this reason, I think the company will have little-to-no value by the end of the decade. Should you invest $1,000 in Quantum Computing right now? Before you buy stock in Quantum Computing, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Quantum Computing wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $636,628!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,063,471!* Now, it's worth noting Stock Advisor's total average return is 1,041% — a market-crushing outperformance compared to 183% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 21, 2025
Globe and Mail
2 hours ago
- Globe and Mail
Can Cava Become the Next Chipotle?
Key Points Cava plans to expand its store presence from less than 400 locations today to 1,000 in 2032. Bullish investors would love for the up-and-coming fast-casual concept to become as big as Chipotle. Chipotle not only has 10 times as many stores as Cava, but the Tex-Mex chain is still growing. 10 stocks we like better than Cava Group › Chipotle Mexican Grill (NYSE: CMG) brought innovation to the restaurant sector, pioneering the fast-casual dining concept and scaling it across the U.S. and beyond. The Tex-Mex chain is a leader in the industry, with strong growth and impressive profitability. Its success has spawned copycats. Cava (NYSE: CAVA) is a Mediterranean-inspired fast-casual restaurant chain that's expanding rapidly itself. But it's much smaller today. That hasn't prevented investors from asking what the business might look like down the road. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » Does Cava have what it takes to one day become the next Chipotle? Here's what investors must know. Opening new stores rapidly Cava is finding success thanks to some key factors. It's betting on consumers' rising interest in healthy food choices. The Mediterranean diet is considered one of the healthiest in the world. What's more, Cava is trying to copy what has worked so well for Chipotle: The fast-casual dining concept. This combines the speed, convenience, and accessibility people appreciate with fast-food restaurants, but it does so with higher-quality ingredients. By benefiting from these two trends, Cava has seen tremendous growth. The company opened 15 net new stores in the fiscal 2025 first quarter (ended April 20), bringing the total to 382. This supported a 28.2% year-over-year gain in revenue, which was boosted by impressive same-store sales (SSS) growth of 10.8%. That figure is noteworthy because it happened during a time when consumer sentiment has been under pressure. Cava's profitability is getting better. Last fiscal quarter, the operating margin came in at 4.7%. This was a meaningful improvement from the 3.6% operating margin from the year-ago period. Looking ahead, the leadership team has plans to get to 1,000 stores by 2032. Expanding the physical footprint by about three-fold would unquestionably lead to much higher revenue and earnings down the road. Cava's biggest bulls hope this happens, and it would get the business closer to Chipotle's size. Don't question Chipotle's dominance To be clear, Chipotle is experiencing a slowdown, as people prioritize getting more value from the money they spend. The company's same-store sales dipped in each of the last two quarters, a very unusual occurrence for the industry leader. Nonetheless, Chipotle is still a top-notch performer in the restaurant market. The business has developed durable competitive advantages, thanks to its scale. Chipotle has 3,839 stores right now, and it raked in $3.1 billion in revenue in the second quarter, both numbers that are light years ahead of Cava. Chipotle has a more visible brand, and its huge sales base allows it to better leverage marketing, product, and technological investments. At its current size, it's easy to argue that Cava hasn't built an economic moat. Its brand is becoming more well-known, and as it scales, there could be some cost advantages. However, I don't see there being any strengths today. I believe there's a very low probability that Cava will get to Chipotle's store count or market cap. Chipotle isn't sitting still. It might be approaching 4,000 stores soon. But over the long term, the company wants to have 7,000 locations open in North America. I don't see Cava ever reaching that level. Chipotle plans to open 330 stores just this year, which is nearly as many as Cava has in total. Investors who are hoping that the Mediterranean chain can catch up to the purveyor of burritos and bowls must seriously temper their expectations. Chipotle has a commanding lead that Cava likely won't chip away at. Cava's valuation is also very expensive. Shares currently trade at a price-to-earnings ratio of 71.9, a whopping 78% more expensive than Chipotle. Cava isn't worthy of investment consideration. Should you invest $1,000 in Cava Group right now? Before you buy stock in Cava Group, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Cava Group wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $636,628!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,063,471!* Now, it's worth noting Stock Advisor's total average return is 1,041% — a market-crushing outperformance compared to 183% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 21, 2025
